Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro

Journal of Experimental Medicine

Volumn 183, Issue 5, 1996, Pages 2247-2257

  Cai, Zeling ^a   Sprent, Jonathan ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; DOSE RESPONSE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPPRESSOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; BINDING SITES; CELLS, CULTURED; DNA; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN-2; ISOANTIGENS; KINETICS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; THYMIDINE; TIME FACTORS;

EID: 0029996649     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.5.2247     Document Type: Article

References (34)

1. Germain, R.N. 1993. Antigen processing and presentation. In Fundamental Immunology. W.E. Paul, editor. Raven Press, New York. 629-676.
2. Janeway, C.A. 1992. The T cell receptor as a multi-component signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-674.
3. Miceli, M.C., and J.R. Parnes. 1993. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53:59-122.
4. Schwartz, R.H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1065-1068.
5. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
6. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
7. Janeway, C.A., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76:275-285.
8. Sprent, J., E.K. Gao, and S.R. Webb. 1990. T cell reactivity to MHC molecules: immunity versus tolerance. Science (Wash. DC). 248:1357-1363.
9. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791-1796.
10. Shahinian, A., K. Pfeffer, K.P. Lee, T.M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P.S. Ohashi, C.B. Thompson, and T.W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science (Wash. DC). 261:609-612.
11. Green, J.M., P.J. Noel, A.I. Sperling, T.L. Walunas, G.S. Gray, J.A. Bluestone, and C.B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:501-508.
12. Maryanski, J.L., P. Pala, J.-C. Cerottini, and H.R. MacDonald. 1988. Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen. Eur. J. Immunol. 18:1863-1866.
13. Auphan, N., J. Curnow, A. Guimezanes, C. Langlet, B. Malissen, A. Mellor, and A.-M. Schmitt-Verhulst. 1994. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice. Eur. J. Immunol. 24:1572-1577.
14. Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. Russell, and D.Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature (Lond.). 335:271-274.
15. Cai, Z., and J. Sprent. 1994. Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179:2005-2015.
16. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell. 69:989-998.
17. Kranz, D.M., S. Tonegawa, and H.N. Eisen. 1984. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 81:7922-7926.
18. Linsley, P.S., J.L. Greene, P. Tan, J. Bradshaw, J.A. Ledbetter, C. Anasetti, and N.K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595-1604.
19. - peritoneal exudate cells. Int. Immunol. 1:517-525.
20. Ljunggren, H.-G., N.J. Stam, C. Ohlen, J.J. Neefjes, P. Hoglund, M. Heemels, J. Bastin, T.N.M. Schumacher, A. Townsend, K. Karre, and H.L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature (Lond.). 346:476-480.
21. b mutations that involve peptide binding. Proc. Natl. Acad. Sci. USA. 87:6186-6190.
22. + T-cell clone. Proc. Natl. Acad. Sci. USA. 90:11272-11276.
23. Sykulev, Y., A. Brunmark, M. Jackson, R.J. Cohen, P.A. Peterson, and H.N. Eisen. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity. 1:15-22.
24. Corr, M., A.E. Slanetz, L.F. Boyd, M.T. Jelonek, S. Khilko, B.K. Al-Ramadi, Y. Sang Kim, S.E. Maher, A.L.M. Bothwell, and D.H. Margulies. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (Wash. DC). 265:946-949.
25. Sykulev, Y., A. Brunmark, T.J. Tsomides, S. Kageyama, M. Jackson, P.A. Peterson, and H.N. Eisen. 1994. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class 1 proteins. Proc. Natl. Acad. Sci. USA. 91:11487-11491.
26. Yang, Y., K. Fruh, J. Chambers, J.B. Waters, L. Wu, T. Spies, and P.A. Peterson. 1992. Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules. J. Biol. Chem. 267:11669-11672.
27. Russell, J.H., P. Meleedy-Rey, D.E. McCulley, W.C. Sha, C.A. Nelson, and D.Y. Loh. 1990. Evidence for CD8-independent T cell maturation in transgenic mice. J. Immunol. 144:3318-3325.
28. + cells in vitro and in vivo. Immunol. Rev. 91:195-218.
29. + T lymphocytes. J. Immunol. 151:5993-6001.
30. Suzuki, G., Y. Kawase, S. Koyasu, I. Yahara, Y. Kobayashi, and R.H. Schwartz. 1988. Antigen-induced suppression of the T proliferative response of T cell clones. J. Immunol. 140: 1359-1365.
31. Critchfield, J.M., M.K. Racke, J.C. Zuniga-Pflucker, B. Cannella, C.S. Raine, J. Goverman, and M.J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (Wash. DC). 263:1139-1143.
32. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.). 372:570-573.
33. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science (Wash. DC). 270:985-988.
34. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.